Journal of Synthesis Science Applied Science Analysis Laboratory Bhakti Wiyata Institute of Health Sciences
Korelasi Kadar Low Density Lipoprotein (LDL) dan Kadar Interleukin-6 Pada Pasien Hiperkolesterolemia
PDF (Bahasa Indonesia)

Keywords

Low Density Lipoprotein (LDL), Interleukin-6 (IL-6), Hiperkolesterolemia

How to Cite

Retnaningsih, N. A., Khoirul Abror, Y., Rohayati, R. and Nurhayati, D. (2025) “Korelasi Kadar Low Density Lipoprotein (LDL) dan Kadar Interleukin-6 Pada Pasien Hiperkolesterolemia ”, Jurnal Sintesis: Penelitian Sains, Terapan dan Analisisnya, 6(2). doi: 10.56399/jst.v6i2.315.

Abstract

Hiperkolesterolemia merupakan gangguan metabolisme lipid yang ditandai dengan peningkatan fraksi lipid, terutama kolesterol total dan kolesterol LDL, dan menjadi penyebab utama aterosklerosis yang meningkatkan risiko penyakit kardiovaskular. Sel pro-inflamasi yang teraktivasi melepaskan Interleukin-6 sebagai respons terhadap stres oksidatif atau kerusakan endotel, serta memainkan peran penting dalam patogenesis aterosklerosis. Penelitian ini bertujuan untuk mengetahui korelasi antara kadar LDL dan kadar IL-6 pada pasien hiperkolesterolemia. Jenis penelitian ini menggunakan analitik observasional dengan teknik purposive sampling. Metode pemeriksaan IL-6 menggunakan metode Fluorescence Immunoassay (FIA). Dari 30 sampel pasien hiperkolesterolemia dengan kriteria kadar kolesterol total > 200mg/dL dan kadar LDL >130mg/dL didapatkan rata-rata kadar LDL yaitu 154.33 mg/dL dan rata-rata kadar IL-6 yaitu 5.79 pg/mL. Hasil uji korelasi Spearman menunjukkan koefisien korelasi sebesar 0.653 sehingga dapat disimpulkan terdapat korelasi positif yang kuat antara kadar LDL dan kadar IL-6 pada pasien hiperkolesterolemia. Hal ini mendukung hipotesis bahwa LDL berperan dalam memicu respons inflamasi sistemik yang terlihat dari kenaikan IL 6, serta berkontribusi pada progresi inflamasi vaskular dan pembentukan plak aterosklerotik.

Kata kunci: Low Density Lipoprotein (LDL), Interleukin-6 (IL-6), Hiperkolesterolemia

 

https://doi.org/10.56399/jst.v6i2.315
PDF (Bahasa Indonesia)

References

Al-Rashed, F., AlSaeed, H., Almansour, N., Mulla, F. A.-, Hannun, Y. A., & Ahmad, R. (2024). IL-6R (trans-signaling) is a key regulator of reverse cholesterol transport in lipid-laden macrophages. https://doi.org/10.1101/2024.02.07.24302472

Bouzidi, N., & Gamra, H. (2023). Relationship between serum interleukin-6 levels and severity of coronary artery disease undergoing percutaneous coronary intervention. BMC Cardiovascular Disorders, 23(1), 586. https://doi.org/10.1186/s12872-023-03570-8

Didion, S. (2017). Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature. International Journal of Molecular Sciences, 18(12), 2563. https://doi.org/10.3390/ijms18122563

El-Mikkawy, D. M. E., EL-Sadek, M. A., EL-Badawy, M. A., & Samaha, D. (2020). Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity. Egyptian Rheumatology and Rehabilitation, 47(1), 7. https://doi.org/10.1186/s43166-020-00003-8

Gaggini, M., Gorini, F., & Vassalle, C. (2022). Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia. International Journal of Molecular Sciences, 24(1), 75. https://doi.org/10.3390/ijms24010075

Klein-Szanto, A. J. P., & Bassi, D. E. (2019). Keep recycling going: New approaches to reduce LDL-C. Biochemical Pharmacology, 164, 336–341. https://doi.org/10.1016/j.bcp.2019.04.003

Malekmohammad, K., Sewell, R. D. E., & Rafieian-Kopaei, M. (2019). Antioxidants and Atherosclerosis: Mechanistic Aspects. Biomolecules, 9(8), 301. https://doi.org/10.3390/biom9080301

Morgado, F., Valado, A., Metello, J., & Pereira, L. (2024). Laboratory markers of metabolic syndrome. Exploration of Cardiology, 2(3), 114–133. https://doi.org/10.37349/ec.2024.00026

Müller, N. (2014). Regulation of Lipoprotein(a) by interleukin-6 in humans. https://nbn-resolving.org/urn:nbn:de:gbv:8-diss-145545

Saragih, A. D. (2020). TERAPI DISLIPIDEMIA UNTUK MENCEGAH RESIKO PENYAKIT JANTUNG KORONER. Indonesian Journal of Nursing and Health Science, 1(1). http://jurnal.globalhealthsciencegroup.com/index.php/IJNHS

Susanti, A. M. (2023). Hubungan Kadar Interleukin 6 (IL-6) dengan Kadar Small Dense-Low Density Lipoprotein (sd-LDL) pada Pasien Penyakit Jantung Koroner (PJK). Penerbit NEM.

Susilo, H., Thaha, M., Pikir, B. S., Alsagaff, M. Y., Suryantoro, S. D., Wungu, C. D. K., Pratama, N. R., Pakpahan, C., & Oceandy, D. (2022). The Role of Plasma Interleukin-6 Levels on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk Scores in Javanese Patients with Chronic Kidney Disease. Journal of Personalized Medicine, 12(7), 1122. https://doi.org/10.3390/jpm12071122

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Authors and Journals

Downloads

Download data is not yet available.